Our studies therefore reveal several lead targets, including SGK2 and PDZK1, that can form the basis for future studies of the specific mechanism(s) involved in γ-secretase inhibition–based rescue in MVID and for future targeting of therapies. This evidence concerns the gene PDZK1 and microvillus inclusion disease.